These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23261978)

  • 21. Gene delivery technologies for cardiac applications.
    Katz MG; Fargnoli AS; Pritchette LA; Bridges CR
    Gene Ther; 2012 Jun; 19(6):659-69. PubMed ID: 22418063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy.
    Bishawi M; Roan JN; Milano CA; Daneshmand MA; Schroder JN; Chiang Y; Lee FH; Brown ZD; Nevo A; Watson MJ; Rowell T; Paul S; Lezberg P; Walczak R; Bowles DE
    Sci Rep; 2019 May; 9(1):8029. PubMed ID: 31142753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene transfer of heterologous G protein-coupled receptors to cardiomyocytes: differential effects on contractility.
    Laugwitz KL; Weig HJ; Moretti A; Hoffmann E; Ueblacker P; Pragst I; Rosport K; Schömig A; Ungerer M
    Circ Res; 2001 Apr; 88(7):688-95. PubMed ID: 11304491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective.
    Hayward C; Banner NR; Morley-Smith A; Lyon AR; Harding SE
    Hum Gene Ther; 2015 May; 26(5):293-304. PubMed ID: 25914929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous approaches for efficient cardiac gene delivery.
    Ishikawa K; Aguero J; Naim C; Fish K; Hajjar RJ
    J Cardiovasc Transl Res; 2013 Aug; 6(4):649-59. PubMed ID: 23749638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Therapy for Heart Failure: Back to the Bench.
    Ylä-Herttuala S
    Mol Ther; 2015 Oct; 23(10):1551-2. PubMed ID: 26442799
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure.
    Poller W; Hajjar R; Schultheiss HP; Fechner H
    Cardiovasc Res; 2010 Jun; 86(3):353-64. PubMed ID: 20176815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in gene therapy for heart failure.
    Yerevanian A; Yerevanian A; Hajjar RJ
    J Cardiovasc Pharmacol; 2014 Feb; 63(2):95-106. PubMed ID: 23921315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of gene therapy as a treatment for heart failure.
    Hajjar RJ
    J Clin Invest; 2013 Jan; 123(1):53-61. PubMed ID: 23281410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for heart failure.
    Njeim MT; Hajjar RJ
    Arch Cardiovasc Dis; 2010; 103(8-9):477-85. PubMed ID: 21074127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.
    Most P; Pleger ST; Völkers M; Heidt B; Boerries M; Weichenhan D; Löffler E; Janssen PM; Eckhart AD; Martini J; Williams ML; Katus HA; Remppis A; Koch WJ
    J Clin Invest; 2004 Dec; 114(11):1550-63. PubMed ID: 15578088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure.
    Bass-Stringer S; Bernardo BC; May CN; Thomas CJ; Weeks KL; McMullen JR
    Heart Lung Circ; 2018 Nov; 27(11):1285-1300. PubMed ID: 29703647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.
    Okada H; Takemura G; Kosai K; Tsujimoto A; Esaki M; Takahashi T; Nagano S; Kanamori H; Miyata S; Li Y; Ohno T; Maruyama R; Ogino A; Li L; Nakagawa M; Nagashima K; Fujiwara T; Fujiwara H; Minatoguchi S
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H616-26. PubMed ID: 19151252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeability.
    Katz MG; Fargnoli AS; Bridges CR
    Hum Gene Ther; 2013 Apr; 24(4):375-92. PubMed ID: 23427834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac gene therapy: from concept to reality.
    Kratlian RG; Hajjar RJ
    Curr Heart Fail Rep; 2012 Mar; 9(1):33-9. PubMed ID: 22143928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling.
    Miyazaki Y; Ikeda Y; Shiraishi K; Fujimoto SN; Aoyama H; Yoshimura K; Inui M; Hoshijima M; Kasahara H; Aoki H; Matsuzaki M
    PLoS One; 2012; 7(4):e35875. PubMed ID: 22558250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure.
    Sundararaman S; Miller TJ; Pastore JM; Kiedrowski M; Aras R; Penn MS
    Gene Ther; 2011 Sep; 18(9):867-73. PubMed ID: 21472007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene transfer in cardiac myocytes.
    Chaudhri BB; del Monte F; Harding SE; Hajjar RJ
    Surg Clin North Am; 2004 Feb; 84(1):141-59, ix-x. PubMed ID: 15053187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The function and significance of SERA2a in congestive heart failure: an analysis of gene therapy trials.
    Wu P; Zhai Y; Li D
    Histol Histopathol; 2017 Aug; 32(8):767-777. PubMed ID: 28134413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.